A Pilot Study of Pharmacokinetics-based Mycophenolate Mofetil Dosing for Graft-Versus-Host-Disease Prophylaxis in Pediatric Blood and Marrow Transplantation
Latest Information Update: 07 Nov 2021
At a glance
- Drugs Mycophenolate mofetil (Primary)
- Indications Graft-versus-host disease
- Focus Adverse reactions; Therapeutic Use
- 13 May 2016 Status changed from active, no longer recruiting to completed.
- 02 Dec 2015 Planned End Date changed from 1 Apr 2016 to 1 Jan 2016 as reported by ClinicalTrials.gov
- 25 Sep 2015 Planned End Date changed from 1 Feb 2015 to 1 Apr 2016 as reported by ClinicalTrials.gov